Webinar: A Faculty Perspective on COIL: A Sheridan Experience!

During the winter 2021 semester, two pilot Collaborative Online International Learning(COIL) courses were conducted within Sheridan - one within the Faculty of Humanities and Social Sciences (FHASS) and the other within Pilon School of Business (PSB). This webinar aims to capitalize on the knowledge gained by our Sheridan members from those pilot courses and learn from their experiences to benefit others moving forward. We will also highlight the different services available for our faculty and staff to support them throughout their COIL journey. Speakers: Peter Galambos, Professor, Faculty of Humanities and Social Sciences – Sheridan Mark Weaver, Professor, Pilon School of Business – Sheridan Stan Kamzol, Professor and International Academic Exchange Coordinator, Pilon School of Business – Sheridan Edwin van den Berg, Professor - Saxion University of Applied Sciences Moderated by: Amira El Masri, Director of the Centre for Global Education and Internationalization – Sheridanhttps://source.sheridancollege.ca/cgei_events/1000/thumbnail.jp

Thermotunneling Based Cooling Systems for High Efficiency Buildings

GE Global Research's overall objective was to develop a novel thermotunneling-cooling device. The end use for these devices is the replacement of vapor cycle compression (VCC) units in residential and commercial cooling and refrigeration systems. Thermotunneling devices offer many advantages over vapor cycle compression cooling units. These include quiet, reliable, non-moving parts operation without refrigerant gases. Additionally theoretical calculations suggest that the efficiency of thermotunneling devices can be 1.5-2x that of VCC units. Given these attributes it can be seen that thermotunneling devices have the potential for dramatic energy savings and are environmentally friendly. A thermotunneling device consists of two low work function electrodes separated by a sub 10 nanometer-sized gap. Cooling by thermotunneling refers to the transport of hot electrons across the gap, from the object to be cooled (cathode) to the heat rejection electrode (anode), by an applied potential. GE Global Research's goal was to model, design, fabricate devices and demonstrate cooling base on the thermotunneling technology

Optimized Phosphors for Warm White LED Light Engines

The objective of this program is to develop phosphor systems and LED light engines that have steady-state LED efficacies (using LEDs with a 60% wall-plug efficiency) of 105–120 lm/W with correlated color temperatures (CCT) ~3000 K, color rendering indices (CRI) >85, <0.003 distance from the blackbody curve (dbb), and <2% loss in phosphor efficiency under high temperature, high humidity conditions. In order to reach these goals, this involves the composition and processing optimization of phosphors previously developed by GE in combination with light engine package modification

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection.

In December of 2013, chikungunya virus (CHIKV), an alphavirus in the family Togaviridae, was introduced to the island of Saint Martin in the Caribbean, resulting in the first autochthonous cases reported in the Americas. As of January 2015, local and imported CHIKV has been reported in 50 American countries with over 1.1 million suspected cases. CHIKV causes a severe arthralgic disease for which there are no approved vaccines or therapeutics. Furthermore, the lack of a commercially available, sensitive, and affordable diagnostic assay limits surveillance and control efforts. To address this issue, we utilized an insect-specific alphavirus, Eilat virus (EILV), to develop a diagnostic antigen that does not require biosafety containment facilities to produce. We demonstrated that EILV/CHIKV replicates to high titers in insect cells and can be applied directly in enzyme-linked immunosorbent assays without inactivation, resulting in highly sensitive detection of recent and past CHIKV infection, and outperforming traditional antigen preparations

Core-collapse explosions of Wolf-Rayet stars and the connection to type IIb/Ib/Ic supernovae

We present non-LTE time-dependent radiative-transfer simulations of supernova (SN) IIb/Ib/Ic spectra and light curves, based on ~1B-energy piston-driven ejecta, with and without 56Ni, produced from single and binary Wolf-Rayet (W-R) stars evolved at solar and sub-solar metallicities. Our bolometric light curves show a 10-day long post-breakout plateau with a luminosity of 1-5x10^7Lsun. In our 56Ni-rich models, with ~3Msun ejecta masses, this plateau precedes a 20-30-day long re-brightening phase initiated by the outward-diffusing heat wave powered by radioactive decay at depth. In low ejecta-mass models with moderate mixing, Gamma-ray leakage starts as early as ~50d after explosion and causes the nebular luminosity to steeply decline by ~0.02mag/d. Such signatures, which are observed in standard SNe IIb/Ib/Ic, are consistent with low-mass progenitors derived from a binary-star population. We propose that the majority of stars with an initial mass ~<20Msun yield SNe II-P if 'effectively" single, SNe IIb/Ib/Ic if part of a close binary system, and SN-less black holes if more massive. Our ejecta, with outer hydrogen mass fractions as low as ~>0.01 and a total hydrogen mass of ~>0.001Msun, yield the characteristic SN IIb spectral morphology at early times. However, by ~15d after the explosion, only Halpha may remain as a weak absorption feature. Our binary models, characterised by helium surface mass fractions of ~>0.85, systematically show HeI lines during the post-breakout plateau, irrespective of the 56Ni abundance. Synthetic spectra show a strong sensitivity to metallicity, which offers the possibility to constrain it directly from SN spectroscopic modelling.Comment: 23 pages, 2 tables, 13 figures, accepted to MNRA

Chaperones convert the energy from ATP into the nonequilibrium stabilization of native proteins.

During and after protein translation, molecular chaperones require ATP hydrolysis to favor the native folding of their substrates and, under stress, to avoid aggregation and revert misfolding. Why do some chaperones need ATP, and what are the consequences of the energy contributed by the ATPase cycle? Here, we used biochemical assays and physical modeling to show that the bacterial chaperones GroEL (Hsp60) and DnaK (Hsp70) both use part of the energy from ATP hydrolysis to restore the native state of their substrates, even under denaturing conditions in which the native state is thermodynamically unstable. Consistently with thermodynamics, upon exhaustion of ATP, the metastable native chaperone products spontaneously revert to their equilibrium non-native states. In the presence of ATPase chaperones, some proteins may thus behave as open ATP-driven, nonequilibrium systems whose fate is only partially determined by equilibrium thermodynamics

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0–100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0–100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8–98·1) in Iceland, followed by 96·6 (94·9–97·9) in Norway and 96·1 (94·5–97·3) in the Netherlands, to values as low as 18·6 (13·1–24·4) in the Central African Republic, 19·0 (14·3–23·7) in Somalia, and 23·4 (20·2–26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1–93·6) in Beijing to 48·0 (43·4–53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6–68·8) in Goa to 34·0 (30·3–38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view—and subsequent provision—of quality health care for all populations.info:eu-repo/semantics/publishedVersio